DLCIG
IBB icon

D.L. Carlson Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

D.L. Carlson Investment Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,190
Closed -$256K – 131
2022
Q3 		$256K Hold
2,190
– – 0.06% 117
2022
Q2 		$258K Hold
2,190
– – 0.05% 119
2022
Q1 		$285K Hold
2,190
– – 0.05% 124
2021
Q4 		$334K Buy
+2,190
New +$339K 0.05% 116
2019
Q1 		– Sell
-3,487
Closed -$336K – 149
2018
Q4 		$336K Buy
+3,487
New +$370K 0.11% 117
2018
Q3 		– Sell
-31,090
Closed -$3.41M – 141
2018
Q2 		$3.41M Sell
31,090
-5,155
-14% -$551K 1.04% 42
2018
Q1 		$3.87M Sell
36,245
-4,495
-11% -$498K 1.22% 35
2017
Q4 		$4.35M Buy
40,740
+66
+0.2% +$7.05K 1.29% 25
2017
Q3 		$4.52M Buy
40,674
+5,853
+17% +$626K 1.4% 25
2017
Q2 		$3.6M Buy
34,821
+8,193
+31% +$807K 1.06% 37
2017
Q1 		$2.6M Buy
26,628
+270
+1% +$25.8K 0.88% 49
2016
Q4 		$2.33M Buy
26,358
+255
+1% +$23.2K 0.79% 59
2016
Q3 		$2.52M Buy
26,103
+2,736
+12% +$260K 0.88% 59
2016
Q2 		$2M Buy
23,367
+9,186
+65% +$824K 0.72% 62
2016
Q1 		$1.23M Sell
14,181
-9
-0.1% -$805 0.46% 79
2015
Q4 		$1.6M Buy
+14,190
New +$1.54M 0.6% 68
2014
Q2 		– Sell
-7,425
Closed -$585K – 132
2014
Q1 		$585K Sell
7,425
-41,493
-85% -$3.46M 0.22% 101
2013
Q4 		$3.7M Sell
48,918
-7,290
-13% -$517K 1.35% 28
2013
Q3 		$3.93M Buy
56,208
+11,943
+27% +$782K 1.51% 21
2013
Q2 		$2.57M Buy
+44,265
New +$2.56M 1.03% 42

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CANY
Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

D.L. Carlson Investment Group's IBB Position: Q4 2022 in Review

D.L. Carlson Investment Group sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 2,190 shares — an estimated $256K sold.

D.L. Carlson Investment Group first reported a position in IBB in Q2 2013 and held it in 20 quarters. The position peaked at $4.52M in Q3 2017. 903 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

  • D.L. Carlson Investment Group reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 2,190 iShares Biotechnology ETF shares in Q4 2022, an estimated $256K.
  • D.L. Carlson Investment Group first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 20 quarters.
  • D.L. Carlson Investment Group's iShares Biotechnology ETF position peaked at $4.52M in Q3 2017.
  • 903 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on D.L. Carlson Investment Group's 13F filing for Q4 2022, filed 13 Feb 2023.